Catalyst Wire Dossier Catalyst Wire Dossier

Insuman Comb 25

insulin human · Sanofi
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Insuman Comb 25, covering 2013-02-27 to 2013-02-27. Get the full timeline:

Most recent: Clinical Trial Update: Assessment of Efficacy and Safety of Insuman Comb 25 Versus Novolin® 30R Twice Daily Over 24 Weeks in Type 2 Diabetes Patients With Insulin Therapy [Phase 3]

See pricing